Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001336844 | SCV001530347 | uncertain significance | Bernard Soulier syndrome | 2018-04-09 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004035815 | SCV004878735 | uncertain significance | not specified | 2023-11-13 | criteria provided, single submitter | clinical testing | The c.215C>T (p.P72L) alteration is located in exon 2 (coding exon 2) of the GP1BB gene. This alteration results from a C to T substitution at nucleotide position 215, causing the proline (P) at amino acid position 72 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692576 | SCV005195285 | uncertain significance | not provided | criteria provided, single submitter | not provided |